يعرض 1 - 10 نتائج من 139 نتيجة بحث عن '"Valcarcel, Bryan"', وقت الاستعلام: 0.78s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المصدر: Salud Pública de México; Vol. 66 No. 3, may-jun (2024); 226-235 ; Salud Pública de México; Vol. 66 Núm. 3, may-jun (2024); 226-235 ; 1606-7916 ; 0036-3634

    مصطلحات موضوعية: prostatic neoplasms, mortality, forecasting, trends, Latin America

    الوصف: Objective. To evaluate the mortality rates of prostate cancer in Latin American and the Caribbean (LAC) countries and predict their mortality to 2030. Materials and methods. The data was retrieved from the World Health Organization mortality database. The age-standardized mortality rates for prostate cancer were estimated per 100 000 men between 1997 and 2017 for most LAC countries. The annual percent change was calculated by country and age group. The Nordpred was used to project prostate cancer mortality to 2030. Results. From 1997 to 2017, the countries with the highest mortality rates from prostate cancer were Trinidad and Tobago, Cuba, and Venezuela. For all ages, ten LAC countries presented significant decreases between -0.5 and -2.8%, whereas Brazil, Cuba, Guatemala, and Venezuela showed increases. Mortality by prostate cancer will increase in 2030 due to changes in the structure and size of the population. Conclusion. Despite the decline in prostate cancer mortality rates over the last two decades in most countries in the region, some countries still have very high mortality rates. By 2030, most countries in the region will show overall increases in the number of deaths, mainly due to population size. ; Objective. To evaluate the mortality rates of prostate cancer in Latin American and the Caribbean (LAC) countries and predict their mortality to 2030. Materials and methods. The data was retrieved from the World Health Organization mortality database. The age-standardized mortality rates for prostate cancer were estimated per 100 000 men between 1997 and 2017 for most LAC countries. The annual percent change was calculated by country and age group. The Nordpred was used to project prostate cancer mortality to 2030. Results. From 1997 to 2017, the countries with the highest mortality rates from prostate cancer were Trinidad and Tobago, Cuba, and Venezuela. For all ages, ten LAC countries presented significant decreases between -0.5 and -2.8%, whereas Brazil, Cuba, Guatemala, and Venezuela showed increases. ...

    وصف الملف: application/pdf

  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية

    المساهمون: National Center for Advancing Translational Sciences, Comprehensive Cancer Center, University of California, Davis, National Institutes of Health, Centers for Disease Control and Prevention, University of Southern California, National Cancer Institute

    المصدر: Clinical Lymphoma Myeloma and Leukemia ; volume 24, issue 4, page e119-e129 ; ISSN 2152-2650

    مصطلحات موضوعية: Cancer Research, Oncology, Hematology

  4. 4
    دورية أكاديمية

    المصدر: Repositorio Institucional - UTP ; Universidad Tecnológica del Perú

    الوصف: Background: Breast cancer is among the leading cause of cancer-related mortality among Latin American and Caribbean (LAC) women, but a comprehensive and updated analysis of mortality trends is lacking. The objective of this study was to determine the breast cancer mortality rates between 1997 and 2017 for LAC countries and predict mortality until 2030. Methods: We retrieved breast cancer deaths across 17 LAC countries from the World Health Organization mortality database. Age-standardized mortality rates per 100,000 women-years were estimated. Mortality trends were evaluated with Joinpoint regression analyses by country and age group (all ages, < 50 years, and ≥ 50 years). By 2030, we predict number of deaths, mortality rates, changes in population structure and size, and the risk of death from breast cancer. Results: Argentina, Uruguay, and Venezuela reported the highest mortality rates throughout the study period. Guatemala, El Salvador, and Nicaragua reported the largest increases (from 2.4 to 2.8% annually), whereas Argentina, Chile, and Uruguay reported downward trends (from − 1.0 to − 1.6% annually). In women < 50y, six countries presented downward trends and five countries showed increasing trends. In women ≥ 50y, three countries had decreased trends and ten showed increased trends. In 2030, increases in mortality are expected in the LAC region, mainly in Guatemala (+ 63.0%), Nicaragua (+ 47.3), El Salvador (+ 46.2%), Ecuador (+ 38.5%) and Venezuela (+ 29.9%). Conclusion: Our findings suggest considerable differences in breast cancer mortality across LAC countries by age group. To achieve the 2030 sustainable developmental goals, LAC countries should implement public health strategies to reduce mortality by breast cancer. ; Campus Lima Centro

    وصف الملف: application/pdf

    العلاقة: BMC Public Health;vol. 23, n° 1449; https://hdl.handle.net/20.500.12867/7812Test; BMC Public Health; https://doi.org/10.1186/s12889-023-16328-wTest

  5. 5
  6. 6
    دورية أكاديمية

    المصدر: BMC Cancer ; volume 23, issue 1 ; ISSN 1471-2407

    مصطلحات موضوعية: Cancer Research, Genetics, Oncology

    الوصف: Background In the last decades, an increasing incidence of testicular cancer has been observed in several countries worldwide. Although mortality rates have been variable in many countries, little information is available from Latin America and the Caribbean (LAC). Therefore, we examined mortality trends of testicular cancer in the last two decades. Methods Age-standardized mortality rates (ASMR) of testicular cancer per 100,000 men-years were estimated using the World Health Organization mortality database from 1997 to 2019. We examined the mortality trends and computed annual percent change (APC) for all ages and the following age groups, 15–29, 30–44, 15–44, and ≥ 45 years. Results Ten countries had mortality rates greater than 0.43 per 100,000 men, with the highest rates for Chile, Mexico, and Argentina. Significant increases in mortality rates were observed in Argentina, Brazil Colombia, and Mexico in all ages, and < 45 years, while Colombia, Ecuador, Mexico, and Peru reported significant downward trends in males aged ≥ 45 years. Only Chile showed significant decreases for all ages and age groups studied. Conclusion Mortality by testicular cancer increased among LAC countries in males of all ages and across age groups. A reduction in mortality rates was observed only in Chilean males of all ages and in men ≥ 45 years in several countries. Strengthening of early detection among symptomatic males may decrease the mortality by this neoplasm.

  7. 7
    دورية أكاديمية

    المساهمون: Universidad Cientifica del Sur

    المصدر: BMC Public Health ; volume 23, issue 1 ; ISSN 1471-2458

    الوصف: Background Breast cancer is among the leading cause of cancer-related mortality among Latin American and Caribbean (LAC) women, but a comprehensive and updated analysis of mortality trends is lacking. The objective of this study was to determine the breast cancer mortality rates between 1997 and 2017 for LAC countries and predict mortality until 2030. Methods We retrieved breast cancer deaths across 17 LAC countries from the World Health Organization mortality database. Age-standardized mortality rates per 100,000 women-years were estimated. Mortality trends were evaluated with Joinpoint regression analyses by country and age group (all ages, < 50 years, and ≥ 50 years). By 2030, we predict number of deaths, mortality rates, changes in population structure and size, and the risk of death from breast cancer. Results Argentina, Uruguay, and Venezuela reported the highest mortality rates throughout the study period. Guatemala, El Salvador, and Nicaragua reported the largest increases (from 2.4 to 2.8% annually), whereas Argentina, Chile, and Uruguay reported downward trends (from − 1.0 to − 1.6% annually). In women < 50y, six countries presented downward trends and five countries showed increasing trends. In women ≥ 50y, three countries had decreased trends and ten showed increased trends. In 2030, increases in mortality are expected in the LAC region, mainly in Guatemala (+ 63.0%), Nicaragua (+ 47.3), El Salvador (+ 46.2%), Ecuador (+ 38.5%) and Venezuela (+ 29.9%). Conclusion Our findings suggest considerable differences in breast cancer mortality across LAC countries by age group. To achieve the 2030 sustainable developmental goals, LAC countries should implement public health strategies to reduce mortality by breast cancer.

  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية

    المصدر: Blood Adv ; ISSN:2473-9537

    الوصف: Compared with the general population, hematopoietic cell transplantation (HCT) survivors are at elevated risk for developing solid subsequent neoplasms (SNs). The Center for International Blood and Marrow Transplant Research (CIBMTR) is a key resource for quantifying solid SN incidence following HCT, but the completeness of SN ascertainment is uncertain. Within a cohort of 18,450 CIBMTR patients linked to the California Cancer Registry (CCR), we evaluated the completeness of solid SN data reported to the CIBMTR during 1991-2018 to understand the implications of using CIBMTR data alone or combined with CCR data to quantify the burden of solid SNs post-HCT. We estimated the cumulative incidence of developing a solid SN, accounting for the competing risk of death. Within the cohort, solid SNs were reported among 724 patients; 15.6% of these patients had an SN reported by CIBMTR-only, 36.9% by CCR-only, and 47.5% by both. The corresponding cumulative incidence of developing a solid SN at 10 years following a first HCT was 4.0% (95% CI=3.5% to 4.4%) based on CIBMTR data only, 5.3% (95% CI=4.9% to 5.9%) based on CCR data only, and 6.3% (95% CI=5.7% to 6.8%) based on both sources combined. The patterns were similar for allogeneic and autologous HCT recipients. Linking detailed HCT information from CIBMTR with comprehensive SN data from cancer registries provides an opportunity to optimize SN ascertainment for informing follow-up care practices and evaluating risk factors in the growing population of HCT survivors.

  10. 10
    دورية أكاديمية